Update on vaginal micronised progesterone soft gel capsule for unexplained threatened miscarriage

Description

In this Product Explainer, Obstetrician and Gynaecologist Dr Hugh Porter explains the role of vaginal micronised progesterone, including the indication, safety profile, clinical trial background and guidelines for use for the treatment and management of threatened miscarriage (6 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Andrew Sindone

Prof Andrew Sindone

An Update on Heart Failure in Primary Care

Dr Gabby Mahoney

Dr Gabby Mahoney

Allergen Introduction – Practical Tips for GPs

Prof Kim Delbaere

Prof Kim Delbaere

Falls Prevention – A Practical, Evidence-Based Update on What Really Works

Dr Stephanie Daly

Dr Stephanie Daly

The New Dementia Test and How they Fit Into the Assessment and Management of the Patient with Cognitive Concerns

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Dr Hugh Porter

expert

Dr Hugh Porter

Obstetrician and Gynaecologist

Date published: 23 September 2025